Clinical Trials Directory

Trials / Unknown

UnknownNCT05740709

Identification of Patients at Risk of CKD After AKI

Identification of Patients at Risk of Chronic Kidney Disease After Acute Kidney Injury

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Guy's and St Thomas' NHS Foundation Trust · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators will investigate whether new kidney biomarkers can identify patients who are at risk of chronic kidney disease after an episode of moderate / severe acute kidney injury in ICU.

Detailed description

Acute kidney injury (AKI) is a common complication during critical illness and associated with serious short and long-term complications. Participants with AKI have an increased risk of developing dysfunction of other organs, including multi-organ failure, a longer stay in hospital and a higher risk of dying. Survivors remain at risk of complications, even if kidney function initially recovers. In particular, they are at high risk of developing chronic kidney disease, dialysis-dependent end-stage kidney disease and cardiovascular comorbidities. At present, the tools to identify patients at highest risk of chronic kidney disease (CKD) are very limited. The investigators will recruit participants who had AKI whilst in ICU and are scheduled to be discharged from hospital. Within 3 days of discharge from hospital, blood and urine kidney biomarkers will be measured to explore whether there is a correlation with renal function 3 months later and to identify those at highest risk of CKD. In addition, quality of life at 3 months will be assessed.

Conditions

Timeline

Start date
2023-03-01
Primary completion
2025-01-01
Completion
2026-01-01
First posted
2023-02-23
Last updated
2024-01-23

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05740709. Inclusion in this directory is not an endorsement.